1. HOXA5 Acts Directly Downstream of Retinoic Acid Receptor β and Contributes to Retinoic Acid–Induced Apoptosis and Growth Inhibition
   Hexin Chen et al, 2007, Cancer Research CrossRef
2. Optimal biological dose: a systematic review in cancer phase I clinical trials
   J. Fraisse et al, 2021, BMC Cancer CrossRef
3. Characterization and therapeutic perspectives of differentiation-inducing therapy in malignant tumors
   Kangwei Zhu et al, 2023, Frontiers in Genetics CrossRef
4. Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy
   Viera Dobrotkova et al, 2018, BMC Cancer CrossRef
5. Valproic acid, in combination with all-trans retinoic acid and 5-aza-2′-deoxycytidine, restores expression of silenced RARβ2 in breast cancer cells
   Nigel P. Mongan et al, 2005, Molecular Cancer Therapeutics CrossRef